Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001881760 | SCV002151702 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2023-03-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1387060). This variant has not been reported in the literature in individuals affected with DCTN1-related conditions. This variant is present in population databases (rs538932463, gnomAD 0.02%). This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 1266 of the DCTN1 protein (p.Gln1266Lys). |
Breakthrough Genomics, |
RCV004693874 | SCV005187766 | uncertain significance | not provided | criteria provided, single submitter | not provided |